Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on August 5, 2025. The filing primarily addresses significant corporate governance changes, including the announcement of the Chief Executive Officer's retirement and the appointment of a new director. The report also references the Company's financial results for the quarter ended June 30, 2025, which were issued via press release on August 7, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained in the attached press release (Exhibit 99.1) and earnings summary (Exhibit 99.2), which are incorporated by reference but not detailed within the body of this 8-K document.
Material Changes and Corporate Events
- CEO Retirement: Dan Burton announced his plan to retire as Chief Executive Officer and principal executive officer, effective June 30, 2026. He will continue to serve on the Board of Directors. The retirement is not the result of any disagreement with the Company.
- Board Expansion and Appointment: The Board expanded from seven to eight directors, effective September 1, 2025. Justin Spencer was appointed to fill the new seat, serving as a Class I director and a member of the Audit Committee.
- Director Compensation: Mr. Spencer will receive a pro-rated $45,000 annual cash retainer for Board service and a pro-rated $10,000 retainer for Audit Committee service. He will also receive an initial award of restricted stock units valued at $225,000, vesting in three equal installments.
Outlook, Risks, and Management Commentary
The Company will conduct a search to identify a successor Chief Executive Officer. The filing includes a cautionary note regarding forward-looking statements, highlighting risks related to executive and director transitions, as well as adverse macro-economic conditions. The Company does not intend to update these forward-looking statements to reflect future events.
Investor Verification Checklist
- Review the attached Q2 2025 earnings release (Exhibit 99.1) for specific financial performance data not included in this summary.
- Monitor the timeline and criteria for the CEO succession search process.
- Verify the impact of the Board expansion on governance structure and committee composition.
- Assess the potential implications of the CEO transition on strategic direction and operational continuity.